TET2 and breast cancer: We collected the mammary glands from Tet2f/+;PyMT (WT-PyMT) and MMTV-Cre;Tet2f/+;PyMT (MUT-PyMT) at 5 weeks of age to verify the effects of Tet2 deletion on the early onset of mammary tumor development.